logo BDSP

Base documentaire


  1. Pharmacy access to syringes among injecting drug users : Follow-up findings from Hartford, Connecticut.

    Article - En anglais

    Objective

    To break the link between drug use and the human immunodeficiency virus (HIV), in 1992 the state of Connecticut rescinded a 14-year ban on pharmacy sales of syringes without a physician's prescription.

    In 1993, the Centers for Disease Control and Prevention (CDC) evaluated the impact of the new legislation on access to syringes among injecting drug users (IDUs) and found an initial pattern of expanded access.

    However, it also found that some pharmacies, after negative experiences with IDU customers, reverted to requiring a prescription.

    This chapter reports findings from a four-year follow-up study of current IDU access to over-the-counter (OTC) pharmacy syringes in Hartford, Connecticut.

    Methods

    Through structured interviews, brief telephone interviews, and mailed surveys, data on nonprescription syringe sale practices were collected on 27 pharmacies, including 18 of the 21 pharmacies in Hartford and nine from pharmacies in contiguous towns, during June and july 1997.

    Interview data on pharmacy syringe purchase from two samples of IDUs, a group of out-of-treatment injectors recruited through street ourtreach, and a sample of users of the Hartford Needle Exchange Program, also are reported.

    Results

    The study found that, while market trends as well as negative experiences have further limited pharmacy availability of nonprescription syringes, pharmacies remain an important source of sterile syringes for IDUs. (...)

    Mots-clés Pascal : SIDA, Virose, Infection, Toxicomanie, Voie intraveineuse, Seringue, Accessibilité, Pharmacie officine, Législation, Prévention, Facteur risque, Evaluation, Homme, Connecticut, Etats Unis, Amérique du Nord, Amérique, Immunopathologie, Immunodéficit

    Mots-clés Pascal anglais : AIDS, Viral disease, Infection, Drug addiction, Intravenous administration, Syringe, Accessibility, Drugstore, Legislation, Prevention, Risk factor, Evaluation, Human, Connecticut, United States, North America, America, Immunopathology, Immune deficiency

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0414229

    Code Inist : 002B05C02D. Création : 22/03/2000.